US Patent Issued to Nibec on Dec. 2 for "Use of peptide for inhibiting functions and expressions of multiple disease biomarkers" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,303, issued on Dec. 2, was assigned to Nibec Co. LTD. (Chungcheongbuk-do, South Korea).

"Use of peptide for inhibiting functions and expressions of multiple disease biomarkers" was invented by Yoon Jeong Park (Seoul, South Korea), Chong-Pyoung Chung (Seoul, South Korea) and Jue-Yeon Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel use of a peptide for inhibiting the functions and expressions of multiple disease biomarkers, and more specifically, to a pharmaceutical composition for treating or preventing inflammation, metabolic diseases or fibrotic diseases, the composition comprisin...